2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

Code: 
2100

Selected funding rounds

Date Company Profile Round Ccy Amount
May 2012 AssureRx Health Inc Personalized medicine company specializing in pharmacogenetics Series C
May 2012 Zurex Pharma Inc N/A
May 2012 Zurex Pharma Inc Series A
Apr 2012 Aldea Pharmaceuticals Inc N/A
Apr 2012 BioRelix Inc Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. N/A USD 269,000
Apr 2012 Tioga Pharmaceuticals Inc Series B
Apr 2012 Tioga Pharmaceuticals Inc Series B
22 Mar 2012 BioRelix Inc Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. N/A USD 2,560,000
15 Mar 2012 Kala Pharmaceuticals Inc Developer of products that penetrate the mucosal barrier to treat a variety of severe diseases Venture
13 Feb 2012 Bind Biosciences Inc Developer of “smart” therapeutic targeted nano-particles capable of differential delivery and controlled drug release to diseased tissue Series D
Feb 2012 Tranzyme Pharma Drug discovery and development, focused on gastroenterology indications Debt
Feb 2012 Auxogyn Inc Series A
Feb 2012 Ceptaris Therapeutics Inc Specialty pharmaceuticals company. Debt
Feb 2012 Collegium Pharmaceutical Inc Collegium Pharmaceutical, Inc., is a privately held pharmaceutical company. N/A
Feb 2012 Collegium Pharmaceutical Inc Collegium Pharmaceutical, Inc., is a privately held pharmaceutical company. N/A
Feb 2012 Cervilenz Inc Series A
5 Jan 2012 3-V Biosciences Inc Biopharmaceutical company discovering and developing novel therapeutics for the treatment of infectious diseases. Venture USD 20,000,000
Jan 2012 QR Pharma Inc Develops drugs for the treatment of mild cognitive impairment, Alzheimer's, Parkinson's, and Down Syndrome diseases
2012 Venturepharma Group Provider of an innovative specialty pharmaceutical company that operates in China. N/A
Jan 2012 Probiodrug Biopharmaceutical company focused on the development of innovative small molecule drugs. Venture

Pages

Selected companies

Company type: 
Drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases.
Company type: 
Pharmaceutical company focused on the development and commercialization of proprietary oral sorbent technology.
Company type: 
Specialty pharmaceutical company, focused on pediatric neurology.
Company type: 
Developer of “smart” therapeutic targeted nano-particles capable of differential delivery and controlled drug release to diseased tissue
Company type: 
AEGEA Medical, Inc. develops and sells medical devices for treatment of abnormal uterine bleeding.
Subscribe to RSS - 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products